|
GALNT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.81869999999318E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.366900E-04 |
| Normal-vs-Stage2 |
4.244200E-04 |
| Normal-vs-Stage3 |
2.119200E-03 |
| Normal-vs-Stage4 |
2.755300E-03 |
| Stage1-vs-Stage2 |
5.099000E-01 |
| Stage1-vs-Stage3 |
8.669800E-01 |
| Stage1-vs-Stage4 |
6.565600E-01 |
| Stage2-vs-Stage3 |
4.969600E-01 |
| Stage2-vs-Stage4 |
8.674200E-01 |
| Stage3-vs-Stage4 |
6.310400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.635900E-04 |
| Normal-vs-AfricanAmerican |
8.430100E-02 |
| Normal-vs-Asian |
6.848900E-04 |
| Caucasian-vs-AfricanAmerican |
6.668600E-01 |
| Caucasian-vs-Asian |
4.775400E-01 |
| AfricanAmerican-vs-Asian |
3.731400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.201310E-03 |
| Normal-vs-Female |
5.88910000000054E-05 |
| Male-vs-Female |
7.489400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.808000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.624210E-04 |
| Normal-vs-Age(61-80Yrs) |
6.408400E-04 |
| Normal-vs-Age(81-100Yrs) |
8.442800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.430400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.998600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.643000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.175200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.616380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.329200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.594800E-01 |
| Classical-VS-Follicular |
1.239370E-03 |
| Classical-VS-Other |
1.858770E-01 |
| Classical-VS-Normal |
6.022000E-03 |
| Tall-VS-Follicular |
1.823920E-02 |
| Tall-VS-Other |
1.535420E-01 |
| Tall-VS-Normal |
4.522200E-01 |
| Follicular-VS-Other |
7.856800E-01 |
| Follicular-VS-Normal |
5.4421999995391E-07 |
| Other-VS-Normal |
7.123300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83904999999651E-05 |
| Normal-vs-N1 |
1.015240E-03 |
| N0-vs-N1 |
8.579000E-01 |
|
|
